Patents by Inventor Valérie Trinquet

Valérie Trinquet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MODULATORS OF ISOVALERYL-COENZYME A DEHYDROGENASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
    Publication number: 20110262451
    Abstract: An in vitro or in vivo method for screening for candidate compounds for the preventive or curative treatment of acne, of seborrhoeic dermatitis or of skin disorders associated with hyperseborrhoea, includes determining the ability of a compound to modulate the expression or the activity of isovaleryl-coenzyme A dehydrogenase (IVD), and also utilizes modulators of the expression or of the activity of this enzyme, for the treatment of acne, of seborrhoeic dermatitis or of skin disorders associated with hyperseborrhoea; methods for the in vitro diagnosis of or in vitro prognosis for these pathologies are also featured.
    Type: Application
    Filed: May 7, 2009
    Publication date: October 27, 2011
    Inventors: Jérôme Aubert, Tony Minier, Valérie Trinquet, Michel Rivier
  • ADFP MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
    Publication number: 20110213009
    Abstract: An in vitro or in vivo method for screening for candidate compounds for the preventive or curative treatment of acne, of seborrhoeic dermatitis or of skin disorders associated with hyperseborrhoea, includes determining the ability of a compound to modulate the expression or the activity of the adipose differentiation-related protein (ADFP), and also utilizes modulators of the expression or of the activity of this protein, for the treatment of acne, of seborrhoeic dermatitis or of skin disorders associated with hyperseborrhoea; methods for the in vitro diagnosis of or in vitro prognosis for these pathologies are also featured.
    Type: Application
    Filed: May 7, 2009
    Publication date: September 1, 2011
    Applicant: Galderma Research & Development
    Inventors: Jérôme Aubert, Sophie Deret, Valérie Trinquet
  • Utilization of FANCC, DAD1, GRIM19 and HADHII genes for the ultimate treatment of psoriasis
    Publication number: 20060115836
    Abstract: Polynucleotide probes relating to the FANCC, DAD1, GRIM19 and HADHII genes are useful for characterizing biological samples and for identifying compounds suited for the treatment of psoriasis.
    Type: Application
    Filed: October 14, 2005
    Publication date: June 1, 2006
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Valerie Trinquet, Patricia Rossio, Paul Fogel